Elite Pharmaceuticals, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Elite Pharmaceuticals, Inc. (ELTP) had Deferred Tax Assets, Operating Loss Carryforwards of $2.49 million as of 2026-03-31, per its 10-K filed 2026-06-29.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-06-29
- 2026-03-31: Deferred Tax Assets, Operating Loss Carryforwards $2.49M.
- 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards $10.66M.
- 2024-03-31: Deferred Tax Assets, Operating Loss Carryforwards $15.53M.
- 2023-03-31: Deferred Tax Assets, Operating Loss Carryforwards $17.61M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-03-31 | $2.49M 10-K · filed 2026-06-29 | |
| 2025-03-31 | $10.66M 10-K · filed 2026-06-29 | |
| 2024-03-31 | $15.53M 10-K · filed 2025-06-30 | |
| 2023-03-31 | $17.61M 10-K · filed 2024-07-01 | |
| 2018-03-31 | $19.21M 10-K · filed 2018-06-14 | |
| 2017-03-31 | $29.91M 10-K · filed 2018-06-14 | $29.91K 10-K · filed 2017-06-14 |
| 2016-03-31 | $27.03M 10-K · filed 2018-06-14 | |
| 2015-03-31 | $24.55K 10-K · filed 2017-06-14 | $24.55M 10-K · filed 2015-06-15 |
| 2014-03-31 | $19.81M 10-K · filed 2016-06-15 |